![](/img/cover-not-exists.png)
DULAGLUTIDE REDUCES HBA1C IRRESPECTIVE OF ANTIHYPERGLYCEMIC AGENTS, DURATION OF DIABETES, BMI AND WEIGHT LOSS: A POST HOC ANALYSIS FROM THE REWIND TRIAL
Kwan, Anita, Gerstein, Hertzel, Xavier, Denis, Basile, Jan, Maldonado, Juan, Raha, Sohini, Konig, ManigeVolume:
75
Journal:
Journal of the American College of Cardiology
DOI:
10.1016/S0735-1097(20)32578-X
Date:
March, 2020
File:
PDF, 170 KB
2020